Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.60 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9975568 | 0.86 | CNR2 (0.60) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL9975563 | 0.78 | FAAH (0.50) | FAAH | |
| SCHEMBL13151436 | 0.76 | CNR2 (1.00) | CNR2KCNK3ALDH1A1THRBBLM | |
| Methanandamide SCHEMBL27775277 | 0.76 | CNR2 (1.00) | CNR2KCNK3ALDH1A1THRBBLM | |
| Methanandamide SCHEMBL4236530 | 0.76 | CNR2 (1.00) | CNR2KCNK3ALDH1A1THRBBLM | |
| Methanandamide SCHEMBL338871 | 0.76 | CNR2 (1.00) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL14384955 | 0.76 | CNR2 (0.74) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL9975595 | 0.75 | CNR2 (0.58) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL22302422 | 0.71 | CNR2 (0.67) | CNR2KCNK3ALDH1A1THRBBLM | |
| SCHEMBL22301829 | 0.71 | CNR2 (0.86) | CNR2KCNK3ALDH1A1THRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202893-B2 | Cannabinergic lipid ligands | UNIVERSITY OF CONNECTICUT (US) | 2012-06-19 | — | — | US | disclosed |
| US-8202893-B2 | Cannabinergic lipid ligands | UNIVERSITY OF CONNECTICUT (US) | 2012-06-19 | — | — | US | disclosed |
| US-20090163557-A1 | Cannabinergic Lipid Ligands | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-06-25 | — | — | US | disclosed |
| US-20090163557-A1 | Cannabinergic Lipid Ligands | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163557-A1 | Cannabinergic Lipid Ligands | FAAH, FAAH2, CNR2 | CNR2 3/4885KCNK3 2154/4885ALDH1A1 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.